Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results (Showing 1 to 20 of 29)As of 23-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
18-Nov-09Caris & CompanyZarak KhurshidRGDX-3Q09 Financials Above Expectations8$254 Stars 4 Stars View Abstract
16-Nov-09Caris & CompanyZarak KhurshidQDEL - Flu Easing Continues9$254 Stars 4 Stars View Abstract
13-Nov-09Caris & CompanyZarak KhurshidVIVO-Tweaking Estimates Post Fiscal 4Q09 Report8$254 Stars 4 Stars View Abstract
12-Nov-09Caris & CompanyZarak KhurshidVIVO-4Q09 Top-line Strong on Flu; EPS Beat Not Spectacular7$254 Stars 4 Stars View Abstract
11-Nov-09Caris & CompanyZarak KhurshidIMA - Solid GM Upside from TMO Distribution Termination7$254 Stars 4 Stars View Abstract
10-Nov-09Caris & CompanyZarak KhurshidSQNM-No New Downs Syndrome Info; 3Q09 Costs Improve8$254 Stars 4 Stars View Abstract
9-Nov-09Caris & CompanyZarak KhurshidVIVO-Fiscal 4Q09 Expected to Outperform on Record Flu Sales7$254 Stars 4 Stars View Abstract
9-Nov-09Caris & CompanyZarak KhurshidQDEL - H1N1 Cases Ease Wk/wk9$254 Stars 4 Stars View Abstract
9-Nov-09Caris & CompanyZarak KhurshidSQNM - Anticipating Uneventful 3Q09 Conference Call6$254 Stars 4 Stars View Abstract
6-Nov-09Caris & CompanyZarak KhurshidGXDX - 3Q09 Tops Estimates8$254 Stars 4 Stars View Abstract
5-Nov-09Caris & CompanyZarak KhurshidILMN-Broad Institute Purchases 30 More Sequencers7$254 Stars 4 Stars View Abstract
5-Nov-09Caris & CompanyZarak KhurshidCPHD - VA North Florida and VA Salem Eyeing Infinity Systems7$254 Stars 4 Stars View Abstract
2-Nov-09Caris & CompanyZarak KhurshidGXDX - Anticipating Solid 3Q09 Financials5$104 Stars 4 Stars View Abstract
2-Nov-09Caris & CompanyZarak KhurshidQDEL - Sky-High Flu Levels Continue10$254 Stars 4 Stars View Abstract
30-Oct-09Caris & CompanyZarak KhurshidEXAR - In-Line Quarter and Guidance7$254 Stars 4 Stars View Abstract
30-Oct-09Caris & CompanyZarak KhurshidGPRO - 3Q09 Sales In-Line9$254 Stars 4 Stars View Abstract
29-Oct-09Caris & CompanyZarak KhurshidCPHD - Good Progress in 3Q099$254 Stars 4 Stars View Abstract
28-Oct-09Caris & CompanyZarak KhurshidIMA- Raising Estimates; Reiterating 1/Buy9$254 Stars 4 Stars View Abstract
28-Oct-09Caris & CompanyZarak KhurshidILMN- Upgrading from 3/Average to 2/Above Average9$254 Stars 4 Stars View Abstract
27-Oct-09Caris & CompanyZarak KhurshidIMA-Quick Take on IMA 3Q09 Results; Blowout Numbers7$254 Stars 4 Stars View Abstract
Next 9

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.